Target intelligence / Profile preview

Immunoglobulin heavy variable (II)-51-2 (pseudogene) (IGHVII-51-2)

Target
IGHVII-51-2
Molecular classification
Other (Immunoglobulin pseudogene)
01

Overview

This gene belongs to the immunoglobulin heavy chain variable region family and carries the designation (II)-51-2, but it is classified as a **pseudogene**. Immunoglobulin heavy chain variable (V) regions are crucial components of antibodies that contribute to antigen specificity and are generated by V(D)J recombination during B-cell development[1][2]. However, as a pseudogene, IGHVII-51-2 contains disruptions or mutations that prevent it from encoding a functional protein product and does not participate in antigen recognition or immune response. The presence of such pseudogenes is a result of evolutionary processes within the immunoglobulin gene loci and does not have a functional or therapeutic role in the immune system[3][4].\n\n**Key points:** \n- It is not a functional molecule, but rather a gene relic (pseudogene), and is not considered a therapeutic or drug discovery target.\n- It should not be confused with functional immunoglobulin heavy chain variable genes, such as IGHV5-51[5], which do participate in immune defense by encoding parts of antibody variable domains. \n- No drugs target this pseudogene, and it is not used as a diagnostic or efficacy biomarker.\n\nIf you intended a different, functional immunoglobulin heavy variable gene, clarify the exact gene name (e.g., IGHV5-51) to receive information on an actual antibody gene/protein.

Other names
IGHV(II)-51-24-51.2PIGHVII512IGHVII-51-2

Beyond the preview

Go deeper on Immunoglobulin heavy variable (II)-51-2 (pseudogene) (IGHVII-51-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable (II)-51-2 (pseudogene) (IGHVII-51-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call